GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BridgeBio Pharma Inc (FRA:2CL) » Definitions » Cash From Other Investing Activities

BridgeBio Pharma (FRA:2CL) Cash From Other Investing Activities : €-0.1 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is BridgeBio Pharma Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

BridgeBio Pharma's cash from other investing activities for the three months ended in Mar. 2025 was €0.0 Mil. It means BridgeBio Pharma received €0.0 Mil from other investing activities. BridgeBio Pharma's cash from other investing activities for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.1 Mil.

BridgeBio Pharma Cash From Other Investing Activities Historical Data

The historical data trend for BridgeBio Pharma's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BridgeBio Pharma Cash From Other Investing Activities Chart

BridgeBio Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash From Other Investing Activities
Get a 7-Day Free Trial -5.68 12.08 113.28 - 24.53

BridgeBio Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.63 -0.09 -0.04 - -

BridgeBio Pharma Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BridgeBio Pharma Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of BridgeBio Pharma's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

BridgeBio Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BridgeBio Pharma Inc (FRA:2CL) » Definitions » Cash From Other Investing Activities
Comparable Companies
BPMC JAZZ HALO MDGL TGTX TECH LEGN NUVL RVMD IONS VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
BBIO:USA 1BBIO:Italy
Address
3160 Porter Drive, Suite 250, Palo Alto, CA, USA, 94304
Website
https://www.bridgebio.com
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

BridgeBio Pharma Headlines

No Headlines